Array BioPharma Inc. · Boulder, CO United States (NASDAQ: ARRY)
| 3200 Walnut St. | Phone: 303-381-6600 |
| Boulder, CO | Fax: 303-386-1390 |
| 80301 | |
| United States | 
Map This Company |
Array BioPharma Inc. Rankings
More Companies in These Related Industries: Toxicology LaboratoriesCompany Description
Array BioPharma wants to offer sufferers of cancer, inflammatory, and metabolic diseases a multitude of treatment options. The development-stage company has seven wholly-owned programs in its development pipeline. Candidates include therapies for solid tumors (ARRY-543), arthritis (ARRY-162), breast cancer (ARRY-380), and type 2 diabetes (ARRY-403). Array also out-licenses some drug programs to
Array BioPharma Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: ARRY Headquarters |
|---|---|
| Fiscal Year-End | June |
| 2011 Employees | 259 |
Executives
33 executives listed for Array BioPharma Inc.'s Boulder, CO location.
| Chairman | Kyle Lefkoff | |
|---|---|---|
| CEO and Director | Robert Conway | |
| President, Chief Scientific Officer, and Director | Kevin Koch |